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Abstract
Background Previous studies revealed microstructural ab-
normalities in prefrontal white matter and corpus callosum
of long-term abstinent chronic methamphetamine abusers.
In view of the importance of the early abstinence period in
treatment retention, we compared 23 methamphetamine-
dependent subjects abstinent from methamphetamine for 7–
13 days with 18 healthy comparison subjects. As certain
metabolic changes in the brain first manifest after early
abstinence from methamphetamine, it is also possible that
microstructural white-matter abnormalities are not yet
present during early abstinence.
Methods Using diffusion tensor imaging at 1.5 T, fractional
anisotropy (FA) was measured in prefrontal white matter at
four inferior–superior levels parallel to the anterior com-
missure–posterior commissure (AC–PC) plane. We also
sampled FA in the corpus callosum at the midline and at
eight bilateral, fiber-tract sites in other regions implicated in
effects of methamphetamine.
Results The methamphetamine group exhibited lower FA in
right prefrontal white matter above the AC–PC plane
(11.9% lower; p=0.007), in midline genu corpus callosum
(3.9%; p=0.019), in left and right midcaudal superior
corona radiata (11.0% in both hemispheres, p’s=0.020 and
0.016, respectively), and in right perforant fibers (7.3%;
p=0.025). FA in left midcaudal superior corona radiata was
correlated with depressive and generalized psychiatric
symptoms within the methamphetamine group.
Conclusions The findings support the idea that metham-
phetamine abuse produces microstructural abnormalities in
white matter underlying and interconnecting prefrontal
cortices and hippocampal formation. These effects are
already present during the first weeks of abstinence from
methamphetamine and are linked to psychiatric symptoms




As methamphetamine (MA) abuse is among the world’s
fastest growing illicit drug problems (Rawson and Condon
2007; United Nations Office on Drug and Crime 2003),
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DOI 10.1007/s00213-009-1761-7neuroimaging has been applied to delineate possible effects
of MA abuse on the brain (reviewed in Barr et al. 2006;
Aron et al. 2007; Baicy and London 2007; Chang et al.
2007; Berman et al. 2008; Payer and London 2009).
Human and animal studies consistently find deficits related
to dopamine function following chronic MA administra-
tion, particularly in striatum and prefrontal cortex (Wilson
et al. 1996; McCann et al. 1998; Volkow et al. 2001; Sekine
et al. 2003). Toxic damage to these and other brain regions
may appear as tissue atrophy or hypertrophy, and several
groups, including our own (Berman et al. 2008; Thompson
et al. 2004), have noted structural abnormalities in cerebral
cortex, nuclear gray matter, and white matter of human
subjects who had abused MA.
In vivo comparisons of the brains of subjects who had
abused MA chronically to those of healthy control (HC)
subjects show larger white-matter volume (Thompson et al.
2004; Bartzokis et al. 2000; Chang et al. 2005), abnormal
tract morphology (Oh et al. 2005), lower levels of the
neuron-associated amino acid N-acetyl-aspartate (Ernst et
al. 2000), higher levels of the glial-associated sugar myo-
inositol (mI; Sung et al. 2007), lower glucose metabolism
(Kim et al. 2005), and higher incidence of white-matter
signal hyperintensities (Bae et al. 2006; Berman et al. 2008,
review). These effects were seen in frontal, temporal, and
occipital lobes and in the corpus callosum. Three studies
used diffusion tensor imaging (DTI), an magnetic reso-
nance imaging (MRI)-based technique that probes white-
matter microstructure (Basser 1995) and showed lower
fractional anisotropy (FA) in prefrontal white matter
(Chung et al. 2007) and genu of corpus callosum (Salo et
al. 2008; Kim et al. 2009) in MA-abusing than in HC
subjects. FA in the MA subjects was correlated with
performance on the Wisconsin Card Sorting and Stroop
Interference tasks. These studies targeted volumes-of-
interest (VOIs) within the frontal lobes (Chung et al.
2007) or corpus callosum (Salo et al. 2008; Kim et al.
2009) and examined subjects who had been abstinent from
MA for 18 days–10 years, suggesting that the observed
abnormalities are long lasting.
Our research team has shown increases in glucose
metabolism in parietal cortices between the first and fourth
weeks of abstinence from chronic MA abuse (Berman et al.
2007), extending a prior finding of abnormally high parietal
cortical glucose metabolism in long-term abstinent MA-
abusing subjects (Volkow et al. 2001). The latter finding
was interpreted as evidence of gliosis, which would be
consistent with elevated cerebral glucose metabolism (Roh
et al. 1998). Notably, exposure of rodents to MA induces
gliosis in brain (Escubedo et al. 1998; Sheng et al. 1994).
Increased cortical glucose metabolism during the first
month of abstinence from MA, therefore, suggests that
gliosis arises and/or increases during this period (Berman et
al. 2007). As mI, abundant in glial cells (Brand et al. 1993),
is elevated in white matter during long-term abstinence
from MA abuse (Sung et al. 2007), gliosis may occur in
white matter as well. In study rationale, we asked whether
white-matter gliosis, or axonal or myelin damage, was
present in the first weeks of abstinence, a critical time for
establishing engagement in therapy, and thus treatment
outcome (Brecht et al. 2000). Identification of white-matter
pathology in this time period might be useful in patient
management or prognosis.
Asone possibleindexofgliosis,wechose tomeasure DTI-
derivedFA.Whereashealthywhitematterhashighdirectional
diffusion and therefore high FA, gliosis is nondirectionally
oriented and hence should reduce FA of local tissue (Jones et
al. 1999). Abnormally low FA has been observed in human
ischemic white-matter signal hyperintensities, lesions which
show gliosis (Jones et al. 1999). Similar inferences have
associated low FAwith gliosis in dorsal posterior cingulate in
patients with Alzheimer’s disease (Ding et al. 2008)a n di n
spinal cord (Agosta et al. 2007) and periventricular white-
matter signal hyperintensities (Bastin et al. 2009)r e l a t e dt o
normal aging. Within-subject correlations between low FA
and reactive gliosis have been verified in mice (Ahrens et al.
1998) and in resected white matter from human epileptic
patients (Dumas de la Roque et al. 2005). Nonetheless,
FA and gliosis were not correlated in postmortem multiple
sclerosis brains (Schmierer et al. 2008), and pathology
other than gliosis (e.g., myelin and/or axonal damage)
may also reduce white-matter FA. In particular in
primates, exposure to amphetamines may lead to both
proximal and terminal serotonin axonal damage following
methamphetamine exposure (reviewed in Ricaurte and
McCann 1992; Huether et al. 1997).
We measured DTI-derived FA in several white-matter
regions in MA-dependent and HC subjects, making
measurements in large (9×9×3 mm
3) axial-oblique white-
matter slabs at four inferior–superior levels deep to bilateral
prefrontal cortex, as in (Chung et al. 2007). In order to
assign putative effects of MA to individual white-matter
tracts connecting with frontal cortex, we also sampled FA in
single DTI voxels at multiple sites along the corpus
callosum, corona radiata, and internal capsule. Moreover,
as we previously found gray-matter volumetric deficits in
hippocampus (Thompson et al. 2004), we sampled single
DTI voxels along the perforant path of the hippocampal
formation, to determine whether white matter innervating
damaged hippocampal cortex is abnormal.
About 50% of adults with amphetamine dependence
experience clinical major depression (Conway et al. 2006).
Major depression and depressive symptoms are prominent
in the first 3 weeks of abstinence from MA abuse
(McGregor et al. 2005) and have been related to glucose
metabolism in pregenual anterior cingulate and amygdala
14 Psychopharmacology (2010) 209:13–24in early abstinence from MA abuse (London et al. 2004).
Other psychiatric symptoms that are common in MA-
abusing subjects include psychosis, anxiety, suicidal
ideation, and hostility (Leventhal et al. 2008; Kalechstein
et al. 2000; Drake et al. 2008). Generalized positive
psychiatric symptoms have been associated with metabo-
lites measured with proton magnetic resonance spectros-
copy (Sekine et al. 2002) and with dopamine transporter
availability (Sekine et al. 2001) in striatum. We therefore
also tested whether regional white-matter microstructural




Twenty-three MA-dependent (13 female, age 32.2±
9.7 years) and 18 HC (seven female, 33.3±8.4 years)
subjects were recruited for the study, which was approved
by the University of California Los Angeles (UCLA)
institutional review board. Subjects were recruited through
local print and radio advertisements and gave written
informed consent after receiving a detailed explanation of
the study. They were paid volunteers. Inclusion require-
ments were as follows: at least moderate intelligence (score
>85 on the Shipley Institute of Living Scale; Zachary et al.
1985), right-handedness (score>20 on a modified Edin-
burgh inventory; Oldfield 1971), absence of current axis I
psychiatric disorders (other than nicotine dependence for all
subjects and MA dependence for MA subjects), and regular
use of tobacco (cigarettes). The MA and HC groups did not
differ significantly in years of smoking or nicotine
dependence. Exclusionary criteria were significant head
trauma with loss of consciousness for any length of time;
neurological, cardiovascular, or pulmonary disease; HIV
seropositivity, and other significant medical conditions.
Subjects who reported mild marijuana (<1 cigarette per
week) and/or alcohol (<14 drinks per week) consumption
were permitted in both groups.
Participants in both groups were administered the
Structured Clinical Inventory for DSM-IVAxis I Disorders
(First et al. 1995), which was used to establish axis I
psychiatric diagnoses. A current axis I diagnosis other than
nicotine dependence and MA dependence for the MA-
dependent group was exclusionary. MA subjects satisfied
DSM-IV criteria for amphetamine dependence (with MA
specified as the amphetamine that was used; First et al.
1995), and MA use within 3 to 4 days of enrollment was
verified with a positive urine screen at enrollment. The MA
subjects stayed at the UCLA General Clinical Research
Center inpatient unit for the duration of the study. Urine
tests were conducted randomly to ensure abstinence. DTI
for MA subjects was acquired within 4–10 days of
admission (i.e., 7–13 days after last MA use). HC subjects
participated on a nonresidential basis and had to demon-
strate a urine screen negative for MA, other drugs of abuse,
and relevant metabolites on day of scan.
Subjects were administered the Beck Depression Inven-
tory (BDI; Beck et al. 1961) and the Brief Symptom
Inventory (BSI; Derogatis and Melisaratos 1983) around
the time of MR scanning in the case of MA subjects within
7 days of admission. Two MA subjects had BDI adminis-
tered and one of these also had BSI administered outside
this timeframe. As correlation results involving BDI and
BSI remained statistically significant when these two
subjects were excluded from analysis, their data were
included. BDI score was used as a measure of depressive
symptoms. The BSI Positive Symptom Total score was
used as a global measure of psychiatric symptoms.
MR image acquisition and processing
DTI acquisition and postprocessing have been described
(Ringman et al. 2007). Data were acquired on a Siemens
Sonata 1.5-T MR scanner. High-resolution, T1-weighted
sagittal whole-brain structural MRI was used for position-
ing. Four sequential, six-direction [(1, 0, 1), (−1, 0, 1),
(0, 1, 1), (0, 1, −1), (1, 1, 0), (−1, 1, 0)] diffusion-weighted
whole-brain volumes were acquired using echo-planar
imaging (repetition time/echo time=6,000/78 ms) parallel
to the anterior commissure–posterior commissure (AC–PC)
plane. The b values were 0 and 1,000 s/mm2 with nominal
voxel size 3×3×3 mm
3. For each subject, the four volumes
were coregistered off-line using FMRIB’s Linear Image
Registration Tool (Jenkinson and Smith 2001) and averaged
together. Eddy current correction was applied using
FMRIB’s Diffusion Toolbox in FSL version 3.2 (Behrens
et al. 2003; Smith et al. 2004). FA maps were created from
the eddy-current corrected file with FSL DTIFIT.
DTI fractional anisotropy: calculation within VOIs,
sampling at fiber-tract sites
Two methods were used to extract regional FA from the
scan data. The first method was similar to one described
before (Chung et al. 2007). FA values were taken from and
averaged across each of four axial-oblique (AC–PC-
aligned) slab VOIs in each frontal lobe. Each VOI was
3×3 DTI voxels square in-plane and 1 voxel deep. Each
VOI was centered within prefrontal white matter and
positioned to avoid contamination from neighboring gray
matter. Within these constraints, the VOI position yielding
the highest average FA value was selected. The four DTI
slabs on which the VOIs were selected were as follows: (1)
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plane, (2) the next slab was at the AC–PC plane, (3) the
third was 6 mm above the AC–PC plane, and (4) the final
slab was 9 mm above (Fig. 1). Special care was taken to
exclude the corpus callosum, identified with the help of FA
color maps indicating the direction of fiber tracts.
The second method, previously described by Ringman et
al. (2007), was used to sample DTI voxels at the following
16 fiber-tract VOIs: midline genu and midline splenium of
corpus callosum; bilateral anterior, midcaudal, and caudal
superior corona radiata; anterior and posterior limbs and
genu of the internal capsule; and perforant path of the
hippocampal formation. For each structure, the two highest
adjacent FA values were recorded and averaged, whereby
FA color maps indicating fiber-tract direction were used to
supplement voxel selection. Anatomic voxel selection for
genu and splenium corpus callosum, anterior corona
radiata, and perforant path was as described (Ringman et
al. 2007). The superior corona radiata appeared on superior
brain slices as a thick inferior–superior tract just lateral to
the lateral ventricle in each hemisphere. Voxels were
selected from midcaudal and caudal cross sections of this
tract at the level of the body of the corpus callosum, i.e., the
level of the superior portions of the lateral ventricles
(Fig. 2). For internal capsule voxels, the axial-oblique slice
where the mesial–lateral distance between the genua of left
and right internal capsule was minimized was identified by
scrolling ventrally through the brain volume. Starting from
that slice, voxels were selected bilaterally from the anterior
limb, genu, and posterior limb of the internal capsule
(Fig. 3).
Both protocols were carried out by two investigators
(MT, MH) who were blind to subject identity or group
assignment. Intrarater reliability scores (intraclass correla-
tion coefficients) were 0.97 (MT) and 0.95 (MH); interrater
reliability was 0.88.
Statistical analysis
Based on Chung et al. (2007), we predicted lower FA in
MA than in HC subjects in the four bilateral prefrontal
white-matter slab VOIs. At each slab VOI, FA for the two
groups was compared using one-way analysis of variance
(ANOVA) with Bonferroni correction for multiple compar-
isons using numbered a priori hypotheses. For bilateral
fiber-tract VOIs, repeated-measures analysis of variance
(R-ANOVA) was performed on the measure FA with
hemisphere and fiber-tract VOI as within-subject factors
and diagnosis as between-subject factor. Given a significant
main effect of diagnosis on FA in R-ANOVA, post hoc
analyses were performed on data from each fiber-tract VOI
using one-way ANOVA. For the two midline fiber-tract
VOIs (genu and splenium corpus callosum), univariate
ANOVAwas used with diagnosis as between-subject factor.
Although the two groups did not differ significantly in
sex, there was a preponderance of females in the MA
group, and effects of sex on frontal white-matter FA have
been reported (Chung et al. 2007). Therefore, for those
VOIs showing a significant effect of diagnosis on FA,
ANOVA was repeated comparing corresponding male-to-
male and female-to-female subgroups.
Effects of diagnosis on BDI and BSI Positive Symptom
Total scores were determined by independent T test. At
VOIs showing a significant effect of diagnosis on FA,
Spearman correlations were performed between FA and
BDI and between FA and BSI Positive Symptom Total
within the MA and HC groups. The criterion for statistical
significance for all tests was p<0.05 two-tailed.
Fig. 1 DTI FA whole-brain col-
or map of an experimental sub-
ject. In the left, an axial-oblique
(at the AC–PC plane) section.
The white box in left prefrontal
white matter (PFWM) indicates
the boundaries of a 3-mm deep
9×9-mm
2 slab across which FA
values were sampled and aver-
aged in postprocessing. A simi-
lar average was obtained for the
right PFWM. In the right,a
parasagittal section of the same
color map depicts the position of
the four parallel prefrontal
white-matter slabs (white bars)
located at the level of the AC–
PC plane (C), 6 mm below (D),
and 6 (B) and 9 (A) mm above.
Left and right PFWM FA aver-
ages were obtained at each level
16 Psychopharmacology (2010) 209:13–24Fig. 2 Axial-oblique (parallel to
AC–PC plane) DTI FA brain
map at level of the upper lateral
ventricles from a study subject.
The same image is shown in
both left and right. In the left,
the green arrow indicates typical
site of DTI voxel selection for
the midcaudal cross section of
the right superior corona radiata
white-matter region. In the right,
the green arrow indicates typical
site for the caudal cross section
of the right superior corona
radiata
Fig. 3 Axial-oblique (parallel to
AC–PC plane) DTI FA brain
map at level of the basal ganglia
from a selected subject. The
same image is shown in all three
panels. In the upper left, the
green arrow indicates typical
site of DTI voxel selection for
the anterior limb of the right
internal capsule white-matter
tract. At the upper right, the
arrow indicates the genu of the
right internal capsule. At bottom
left, the arrow indicates the
posterior limb of the right
internal capsule
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Subjects
The two subject groups (Table 1) did not differ significantly
in sex (χ
2=2.05, p=0.16), age (t (38.6)=0.37, p=0.72), or
alcohol consumption (t(28.4)=1.08, p=0.29). All subjects
were smokers and the groups did not differ significantly in
years of smoking (t(33.7)=0.51, p=0.61) or scores on the
Fagerström Test for Nicotine Dependence (t(40)=1.32,
p=0.20).
Fractional anisotropy in regional brain white matter
Mean regional values of FA for the MA and HC groups are
shown in Tables 2 and 3. Table 2 includes the prefrontal
slab VOIs. A priori hypotheses were formulated for these
VOIs based on a prior report (Chung et al. 2007). Table 3
includes the single-voxel fiber-tract sites, for which no a
priori hypotheses were formulated but rather omnibus
R-ANOVA was performed. FA was lower in MA than in
HC subjects in all eight prefrontal white-matter slab VOIs
studied, but the difference was only significant in right
prefrontal white matter 6 mm superior to AC–PC (11.9%;
F(1, 35)=8.0, p=0.007; Fig. 4). R-ANOVA across the 16
single-voxel white-matter tract sites yielded a significant
effect of diagnosis on FA (F(1, 37)=5.4, p=0.026; Table 3)
with lower FA in MA than in HC subjects at 12 of 16 sites.
In protected post hoc one-way ANOVAs following R-
ANOVA comparisons, the difference was significant only
in genu corpus callosum (3.9%; F(1, 40)=6.0, p=0.019),
left (11.0%; F(1, 40)=5.9, p=0.020) and right (11.0%; F(1,
40)=6.4, p=0.016, Fig. 4) midcaudal superior corona
radiata, and right perforant path (7.3%; F(1, 40)=5.4,
p=0.025). FA at the midline genu corpus callosum site
decreased significantly with years of MA abuse (Spearman,
r=−0.44, p=0.036), but the correlation was not significant
at other sites.
Effects of sex on white-matter fractional anisotropy
Chung et al. (2007) observed effects of sex on white-matter
FA within their MA sample. Therefore at each site where
the between-group difference in FA was significant, we
reexamined the difference for the separate male and female
subgroups. Among female subjects, FA was significantly
lower for MA than for HC subjects in right prefrontal white
matter 6 mm superior to the AC–PC (F(1, 19)=5.2, p=
0.034), genu corpus callosum (F(1, 19)=6.0, p=0.025), and
left (F(1, 19)=7.2, p=0.015) and right (F(1, 19)=6.1, p=
0.036) midcaudal superior corona radiata, i.e., in all regions
except right perforant path. In right perforant path, FA
tended to be lower for male MA than for male HC subjects
(F(1, 20)=3.0, p=0.099), but there was no significant
between-group difference for males in right prefrontal white
matter 6 mm superior to the AC–PC, genu corpus callosum,
or midcaudal superior corona radiata.
Correlations between white-matter FA and psychiatric
symptoms
Mean BDI score was significantly higher in the MA (15.4±
14.1) than in the HC (1.8±2.5) group (t(38)=3.9, p=
0.00013); as was the mean BSI Positive Symptom Total
score (MA 21.9±14.5, HC 3.1±4.7; t(38)=5.0, p=
0.0000029). In left midcaudal superior corona radiata
Subjects MA group (n=23) HC group (n=18)
Mean n SD % Mean n SD %
Age (years) 32.2 9.7 33.3 8.4
Tobacco (cigarettes/day) 10.5 6.4 16.7 7.0
Tobacco (years) 13.4 9.4 13.6 6.9
Tobacco (Fagerström score) 3.4 1.9 4.2 1.8
Alcohol (drinks/week) 1.8 1.9 2.6 2.4
MA abuse (g/week) 3.8 4.0 ––
MA abuse (years) 8.0 7.0 ––
Sex (men) 10 43.5 11 61.1
Handedness (right) 23 100 18 100
Tobacco users 23 100 18 100
Alcohol users 11 47.8 12 66.7
Lifetime cannabis 9 39.1 1 5.6
Lifetime cocaine 5 21.7 0 0
Table 1 Characteristics
of methamphetamine-dependent
and healthy control subjects
MA methamphetamine abuser,
HC healthy control, SD standard
deviation
18 Psychopharmacology (2010) 209:13–24within the MA group (Fig. 5), FA correlated positively with
BDI (r=0.44, p=0.038) and BSI Positive Symptom Total
(r=0.51, p=0.014). No significant correlations resulted for
the MA group at the other anatomic sites where effects of
diagnosis on FA had been observed. No significant
correlations resulted for the HC group at any sites where
effects of diagnosis on FA were observed. Because the BSI
Positive Symptom Total is comprised of items from several
subscales, correlations were calculated between left mid-
caudal superior corona radiata FA and the scores from the
BSI subscales. Significant positive correlations (p<0.05)
were found for the depression, somatization, obsessive–
compulsive, interpersonal sensitivity, paranoid ideation, and




A DTI investigation of brain white matter in adult MA
subjects revealed modest (3–12%) decrements in FA in
multiple regions, including right prefrontal white matter
above the AC–PC plane, bilateral midcaudal superior
corona radiata, genu corpus callosum, and right perfo-
rant path. Among MA-dependent subjects, the left
midcaudal superior corona radiata showed a positive
correlation of FA with standard clinical indices of
severity of depressive and general psychiatric positive
symptoms. Low FA indicates low tissue integrity and/or
organization, possibly due to increased extracellular
Table 2 Prefrontal FA in methamphetamine-dependent and healthy control subjects
Volume of interest MA group (n=23) HC group (n=18)
6 mm inferior to AC–PC plane, left 0.431±0.083 0.434±0.082
6 mm inferior to AC–PC plane, right 0.462±0.065 0.471±0.107
at AC–PC plane, left 0.478±0.071 0.498±0.077
at AC–PC plane, right 0.490±0.045 0.501±0.090
6 mm superior to AC–PC plane, left 0.413±0.066 0.434±0.073
6 mm superior to AC–PC plane, right 0.409±0.055* 0.465±0.071
9 mm superior to AC–PC plane, left 0.387±0.061 0.403±0.053
9 mm superior to AC–PC plane, right 0.398±0.062 0.426±0.066
Data are group means±standard deviation
FA fractional anisotropy, AC–PC anterior commissure–posterior commissure, MA methamphetamine abuser, HC healthy control
*p<0.01 (ANOVA Bonferroni corrected for multiple comparisons with a priori hypotheses)
Volume of interest MA group (n=23) HC group (n=18) Effect size
Genu corpus callosum 0.848±0.048* 0.882±0.041 −0.74
Splenium corpus callosum 0.879±0.069 0.900±0.052 −0.33
Left anterior corona radiata 0.572±0.060 0.597±0.074 −0.37
Right anterior corona radiata 0.570±0.067 0.580±0.085 −0.13
Left midcaudal superior corona radiata 0.387±0.050* 0.435±0.075 −0.75
Right midcaudal superior corona radiata 0.382±0.060* 0.429±0.058 −0.77
Left caudal superior corona radiata 0.478±0.067 0`506±0.076 −0.38
Right caudal superior corona radiata 0.482±0.061 0.473±0.061 0.15
Left internal capsule anterior limb 0.523±0.074 0.533±0.071 −0.13
Right internal capsule anterior limb 0.537±0.065 0.522±0.073 +0.21
Left genu internal capsule 0.617±0.052 0.633±0.063 −0.27
Right genu internal capsule 0.636±0.069 0.635±0.065 +0.01
Left internal capsule posterior limb 0.708±0.040 0.707±0.040 +0.02
Right internal capsule posterior limb 0.721±0.050 0.744±0.036 −0.50
Left perforant path 0.523±0.053 0.532±0.069 −0.14
Right perforant path 0.504±0.04* 0.543±0.068 −0.70
Table 3 FA at fiber tract in
methamphetamine-dependent
and healthy control subjects
Data are group means ± stan-
dard deviation
FA fractional anisotropy, MA
methamphetamine abuser, HC
healthy control




Psychopharmacology (2010) 209:13–24 19water space between fibers and/or deviant course of a
portion of the fibers in a voxel (although the latter
possibility is reduced in callosal VOIs as those regions
contain highly parallel fibers). The results suggest that
such aberrant microstructure arises as a neuropatholog-
ical effect at times of active MA abuse, or may occur in
early abstinence from MA abuse. Notably, in rats, three
daily exposures to MA are sufficient to induce reactive
gliosis lasting 14–21 days (Pennypacker et al. 2000). It
is also possible that the white-matter differences seen in
our study reflect effects that predated MA abuse. In any
case, it is likely that the abnormally low regional FA
observed in later remission from MA abuse (Chung et al.
2007;S a l oe ta l .2008;K i me ta l .2009) has origins in
earlier stages of the disease. Specific white-matter pathol-
ogies contributing to low FA could include myelin and/or
axonal damage and gliosis.
Prefrontal white-matter abnormalities
Our observation of low FA in right prefrontal white-
matter superior to the AC–PC plane in the MA group
replicates a prior finding (Chung et al. 2007)a t5m m
above the AC–PC plane. In the earlier report (Chung et al.
2007), the HC subjects in aggregate smoked less tobacco
than the MA subjects. In our study, the HC subjects did
not smoke less than MA subjects, but the right prefrontal
FA finding was similar in both studies. This finding,
therefore, is likely associated with MA rather than tobacco
abuse. Chung et al. (2007)a l s oo b s e r v e d7 –12% lower FA
in their MA than in their control sample in bilateral
prefrontal white matter at the AC–PC level. We observed
2–4% decrements in FA in our MA group at those sites,
but the differences did not reach statistical significance. It
is possible that with the higher field strength (3 T), spatial
Fig. 4 Key findings for FA obtained in right prefrontal white matter
using the methods of Chung et al. (2007; left) and Ringman et al.
(2007; right)i nM A( solid diamonds) and age-matched HC (open
squares) subjects. Group means given by horizontal bars. Mean FA of
MA subjects was significantly below that of the HC group in an axial-
oblique slab of right prefrontal white matter centered 6 mm above the
anterior commissure–posterior commissure (AC–PC) plane. Lower FA
of MA subjects than HC subjects at a midcaudal site along the
superior portion of the right corona radiata indicates that this specific
tract may be vulnerable to MA abuse
Fig. 5 Relationship of fractional anisotropy (FA) in left midcaudal
corona radiata to psychiatric symptoms in MA subjects (solid
diamonds). Symptoms were evaluated within 7 days of admission
for supervised MA abstinence. Rather than the anticipated negative
association, FA was significantly positively related to depressive
symptoms (BDI score; r=0.44, p=0.038) and with generalized
psychiatric symptoms (Brief Symptom Inventory Positive Symptom
Total; r=0.51, p=0.014)
20 Psychopharmacology (2010) 209:13–24resolution (0.9375×0.9375×3.5 mm
3), and number of
DTI gradients (Berman et al. 2007)u s e di nt h ep r i o r
report (Chung et al. 2007), significant differences might
have been evident in our sample as well. These findings
reinforce a notion from previous structural MRI (Bae et al.
2006) and magnetic resonance spectroscopy (Ernst et al.
2000;S u n ge ta l .2007) investigations and studies of
cerebral glucose metabolism (Kim et al. 2005) that frontal
white matter and possibly other later-myelinating regions
are particularly vulnerable to MA abuse. Our measure-
ments of lower FA in the MA than in the healthy control
group in corona radiata, however, suggest that additional
fiber tracts are involved.
Callosal abnormalities
At 1.5 T using six-direction DTI with 1.875×1.875×5 mm
3
voxels, Salo et al. (2008) observed 4.8% lower mean FA
(trend) in a VOI encompassing the genu of the corpus
callosum in MA-abusing vs. HC subjects. In a VOI
encompassing the splenium, they found no significant
between-group difference. We detected statistically sig-
nificant 3.9% lower FA in the genu and no significant
effect in the splenium in the MA group, replicating the
findings of Salo et al. (2008) and those of Kim et al.
(2009), who recorded highly significant 4.3% lower FA of
the genu in MA subjects. As white-matter fibers passing
through the genu interconnect left- and right-hemisphere
dorsolateral prefrontal cortices (Pandya and Seltzer 1986),
these findings indicate that white-matter innervating
prefrontal cortex is particularly involved in the effects of
MA abuse. Few (four of 17) HC subjects were tobacco
smokers in the Salo study (Salo et al. 2008)c o m p a r e dt o
100% in our study. This, again, suggests that the genual
FA finding is particularly characteristic of MA and not
tobacco abuse (in 24, lifetime nicotine exposure was
permitted for MA subjects, but no details on tobacco use
are provided).
Prefrontal white matter and the genu of the corpus
callosum are both late-myelinating and, therefore, more
vulnerable to damage than the early-myelinating splenium
and internal capsule (Yakovlev and Lecours 1967). While it
is known that catecholamines (primarily dopamine and
serotonin) and acetylcholine can impact oligodendrocyte
differentiation and myelination, the exact mechanisms and
their impact on early versus late myelination are unclear
(Bartzokis 2007; Belachew 1999; Bongarzone 1998; Roy
2007). The genu FA group difference also suggests that the
FA differences in other late-myelinating regions are
unlikely to be due to more fiber crossing in the MA group
(since in the genu, the fibers are parallel), and the
underlying process may reflect MA toxicity or preexisting
poor myelination.
Hippocampal formation abnormalities
We measured lower FA in MA than in HC subjects, in
right perforant path, a white-matter tract not analyzed
by earlier studies of MA abuse. Considering our prior
observation of morphometric abnormalities in the hip-
pocampus of MA subjects (Thompson et al. 2004), the
present finding suggests that white-matter microstructural
effects may contribute to neuropathology in the hippo-
campal formation of MA-dependent subjects. Note that
the perforant path is a late-myelinating region (Benes et al.
1994; Arnold and Trojanowski 1996;B e n e s1989). In
general (with the possible exception of the corona radiata
findings), our findings seem to be limited to more
vulnerable later-myelinating structures. These results
suggest a developmental problem that is either inherent
or due to MA. The findings of FA being lower in the MA
than the HC subjects are consistent with gliosis or other
white-matter pathology, such as myelin and/or axonal
damage or loss.
Sex differences
With the exception of right perforant path, at every white-
matter site where below-normal FA was observed for the
overall (male + female) MA group, the same FA effect was
manifest for the comparison involving only female subjects.
For the comparison involving only male subjects, the MA-
associated effect was seen only (and as a trend) in the right
perforant path. Thus, overall findings of FA being below
HC values were driven by female MA subjects at all but
one site. Observations of low FA reported before (Chung et
al. 2007), in contrast, were driven by male MA subjects.
Salo et al. (2008) reported no effect of sex on MA-
associated below-normal FA in genu corpus callosum, and
Kim et al. (2009) reproduced this finding in an all-male
sample. Since similar effects on FAwere seen in the studies
with an excess of male (Chung et al. 2007; Kim et al. 2009)
and an excess of female (Salo et al. 2008; present study)
MA subjects, these effects apparently occur in both sexes. It
also argues against the suggestion that below-normal FA is
not observed in white matter of female MA subjects due to
neuroprotective effects of estrogen (Chung et al. 2007).
Moreover, the failure to find significantly below-normal FA
in males in our study and in females previously (Chung et
al. 2007) may reflect insufficient numbers of male and
female subjects in the two studies, respectively. There were
no significant differences between the male and female
subsamples of the MA group in years of MA abuse (male
7.4±6.4 years, female 8.5±7.7 years; t(21)=0.076,
p=0.72), age at first abuse (male 25.9±7.7 years, female
23.0±8.9 years; t(21)=0.17, p=0.42), or years of education
(male 12.7±2.1 years, female 12.5±1.6 years; t(21)=0.05,
Psychopharmacology (2010) 209:13–24 21p=0.77). Thus, these factors are unlikely to explain the
observed sex differences in regional FA.
Correlations of FA with depressive and generalized
psychiatric symptoms
Mean scores on the BDI (774% higher) and BSI Positive
Symptom Total (615% higher) clinical rating scales were
much higher for the MA than for the HC group. This is
consistent with earlier findings on MA subjects in the first
three weeks of abstinence (McGregor et al. 2005; London
et al. 2004), the high lifetime prevalence of depression in
individuals who have abused MA (Conway et al. 2006),
and the high prevalence of generalized psychiatric symp-
toms in subjects who engage in MA abuse (Leventhal et al.
2008; Kalechstein et al. 2000; Drake et al. 2008). The
present study uncovered correlations between scores on
rating scales and FA in left midcaudal superior corona
radiata, white matter forming direct two-way connections
between frontal cortex and the brain stem and spinal cord.
Thus, DTI may join positron emission tomography
(London et al. 2004; Sekine et al. 2001) and magnetic
resonance spectroscopy (Sekine et al. 2001) as human in
vivo neuroimaging modalities with potential to map
psychiatric function in MA abuse. As to the functional
significance of the specific effects observed, the BSI
subscales contributing to the correlation (depression,
somatization, obsessive–compulsive, interpersonal sensi-
tivity, paranoid ideation, and phobic anxiety) are all
conditions that may entail rumination and cyclic internally
verbalized anxiety as a feature. Since the time of Moniz
(1936), it has been known that prefrontal leukotomy may
alleviate conditions such as anxious neuroses, depression,
obsessive–compulsive disorder, and psychosis. In a sim-
ilar manner, MA-abusing subjects with (especially left
hemisphere) prefrontal white-matter FA in the lower range
may have sustained damage to neural circuits that support
ruminative mental activity resulting in lower scores on the
BSI and its subscales. Alternatively, MA-abusing subjects
with higher premorbid FA may possess a higher capacity
for expressing these symptoms.
Our findings further suggest that regional FA of brain
white matter reflects not only frontal executive functions
(Wisconsin Card Sorting; 22) and selective attention and
response inhibition (Stroop Interference; 23–24) but also
mood and psychiatric symptoms. In the other studies cited,
regional FA was lower for MA subjects with higher
functional impairment (lower task performance). In our
study, in contrast, regional FA was higher for MA subjects
with more severe mood and psychiatric dysfunction (higher
BDI and BSI Positive Symptom Total scores). Thus, even
though mean FAwas lower for MA than for HC subjects as
a group, within the MA group, those subjects reporting
worse symptoms registered higher FA values. We do not
know the reason for these counter-intuitive results, which
may be chance findings; however, we offer that those MA
subjects with more intact white matter (higher FA) may be
more aware of their own illness and/or be more willing to
endorse symptoms. Along these lines, we observed a similar
positive correlation of BDI score with gray matter volume in
prefrontal cortex in a larger but overlapping sample of MA
subjects (A. Morales et al., manuscript in review).
Limitations and strengths
Limitations of this study include modest sample size and the
DTI acquisition protocol (1.5 T, six DTI directions, relatively
large voxels). Nonetheless, using this sample size and these
relatively gross acquisition parameters, we reproduced and
amplified prior regional FA findings. Strengths of this study
include defining a relatively narrow period of abstinence for
study and the inclusion of samples in which HC subjects were
all tobacco smokers, addressing the specificity of MA effects
beyond those of cigarette smoking. This suggests that
diminished FA represents a robust feature of white-matter
pathology in the brains of humans who abuse MA. Prospec-
tive studies are needed to address cause-and-effect issues.
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